CMS proposes two long-awaited Medicare drug pricing demosnews2025-12-22T19:16:42+00:00December 22nd, 2025|Endpoints News|
FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rivalnews2025-12-19T22:01:44+00:00December 19th, 2025|Endpoints News|
Senators point fingers over who blocked the rare disease voucher reauthorizationnews2025-12-19T15:43:21+00:00December 19th, 2025|Endpoints News|
Catalent handed two Form 483s for Maryland gene therapy sitesnews2025-12-19T12:25:40+00:00December 19th, 2025|Endpoints News|
Daiichi and Merck’s I-Dxd lung cancer study faces partial hold due to deathsnews2025-12-18T20:36:26+00:00December 18th, 2025|Endpoints News|
CDC stops recommending universal hepatitis B birthdosenews2025-12-17T17:19:16+00:00December 17th, 2025|Endpoints News|
GSK formally submits new leucovorin indication to FDAnews2025-12-17T16:20:50+00:00December 17th, 2025|Endpoints News|
GSK wins FDA approval for long-acting asthma drugnews2025-12-17T00:21:14+00:00December 17th, 2025|Endpoints News|
Makary walks back talk of Covid-19 vaccine risk amid internal FDA debatenews2025-12-16T20:05:09+00:00December 16th, 2025|Endpoints News|
FDA extends decision on Aldeyra’s dry eye disease drugnews2025-12-16T12:14:30+00:00December 16th, 2025|Endpoints News|
